Bristol Myers: presents 90 studies at Paris congress
(CercleFinance.com) - Bristol Myers Squibb today announced that it will present scientific research on several solid tumours that illustrate the breadth of the company's oncology development program at the European Society of Medical Oncology 2022 Congress in Paris from 9 to 13 September.
Over 90 Bristol Myers Squibb-sponsored studies will be presented.
The research reinforces the depth and breadth of its development program, which covers early and late stage cancer. This clinical research program and transformative science are helping the group to improve long-term outcomes for people with cancer, the group said.
We look forward to sharing data and engaging with the scientific community on how critical work in this area can continue to improve the lives of patients, it added.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
Over 90 Bristol Myers Squibb-sponsored studies will be presented.
The research reinforces the depth and breadth of its development program, which covers early and late stage cancer. This clinical research program and transformative science are helping the group to improve long-term outcomes for people with cancer, the group said.
We look forward to sharing data and engaging with the scientific community on how critical work in this area can continue to improve the lives of patients, it added.
Copyright (c) 2022 CercleFinance.com. All rights reserved.